X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. STERLING BIOTECH FDC LTD./
STERLING BIOTECH
 
P/E (TTM) x 17.5 -1.8 - View Chart
P/BV x 3.6 0.1 5,321.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   STERLING BIOTECH
EQUITY SHARE DATA
    FDC LTD.
Mar-14
STERLING BIOTECH
Dec-13
FDC LTD./
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs14411 1,366.7%   
Low Rs793 2,323.5%   
Sales per share (Unadj.) Rs47.626.8 177.4%  
Earnings per share (Unadj.) Rs7.6-15.0 -50.9%  
Cash flow per share (Unadj.) Rs9.0-5.5 -164.9%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.554.9 86.6%  
Shares outstanding (eoy) m177.83267.87 66.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.3 902.1%   
Avg P/E ratio x14.6-0.5 -3,146.4%  
P/CF ratio (eoy) x12.3-1.3 -970.5%  
Price / Book Value ratio x2.30.1 1,848.2%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7841,862 1,062.7%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m1,221547 223.2%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m8,4597,181 117.8%  
Other income Rs m39443 923.8%   
Total revenues Rs m8,8527,223 122.5%   
Gross profit Rs m2,070947 218.6%  
Depreciation Rs m2492,543 9.8%   
Interest Rs m314,377 0.7%   
Profit before tax Rs m2,184-5,931 -36.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606-1,924 -31.5%   
Profit after tax Rs m1,353-4,007 -33.8%  
Gross profit margin %24.513.2 185.6%  
Effective tax rate %27.732.4 85.5%   
Net profit margin %16.0-55.8 -28.7%  
BALANCE SHEET DATA
Current assets Rs m4,35514,335 30.4%   
Current liabilities Rs m1,79249,809 3.6%   
Net working cap to sales %30.3-494.0 -6.1%  
Current ratio x2.40.3 844.5%  
Inventory Days Days44403 11.0%  
Debtors Days Days25171 14.5%  
Net fixed assets Rs m3,02555,432 5.5%   
Share capital Rs m179268 66.7%   
"Free" reserves Rs m8,24313,935 59.1%   
Net worth Rs m8,45314,701 57.5%   
Long term debt Rs m119,478 0.1%   
Total assets Rs m10,55773,988 14.3%  
Interest coverage x71.4-0.4 -20,119.4%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.80.1 825.6%   
Return on assets %13.10.5 2,617.6%  
Return on equity %16.0-27.3 -58.7%  
Return on capital %23.5-6.4 -365.8%  
Exports to sales %13.325.9 51.4%   
Imports to sales %3.30.2 1,967.9%   
Exports (fob) Rs m1,1261,860 60.5%   
Imports (cif) Rs m28312 2,318.0%   
Fx inflow Rs m1,1461,860 61.6%   
Fx outflow Rs m35525 1,427.5%   
Net fx Rs m7911,835 43.1%   
CASH FLOW
From Operations Rs m1,4851,719 86.4%  
From Investments Rs m-620-3,148 19.7%  
From Financial Activity Rs m-7531,426 -52.8%  
Net Cashflow Rs m113-3 -3,317.6%  

Share Holding

Indian Promoters % 68.9 33.9 203.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 0.0 -  
FIIs % 7.5 9.9 75.8%  
ADR/GDR % 0.0 16.9 -  
Free float % 19.0 39.3 48.3%  
Shareholders   23,730 21,482 110.5%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - FRESENIUS KABI ONCO. COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS